MOREPENLAB

Morepen : Co Bags ₹825 Cr Global CDMO Deal • 💰 Major Order Win: Secures multi-year CDMO mandate worth ~₹825 crore from a global pharma major. • 🌍 CDMO Expansion: Marks strong entry into high-growth contract manufacturing segment. • 🏭 Execution Timeline: Supplies to begin in 4–5 months; execution through next financial year. • 📈 Scale & Credibility: Enhances global manufacturing footprint and regulated market presence. • 🔧 Capacity Focus: Company evaluating capacity and technology investments to support growth. 🟢 Impact: Positive Large global CDMO win strengthens revenue visibility and supports long-term growth outlook.